Category: Diabetes 101

Prescribed medication is popular all over the world but a major health concern in the United States is a problem referred to as “non-adherence”. This simply means that people are not taking the medication correctly that has been prescribed to them. When this happens, health issues like diabetes and chronic diseases become more of an issue.

A study that was led by researchers at the University of California, San Francisco, San Francisco General Hospital and Trauma Center and the Kaiser Permanente Division of Research has found a reason as to why medical non-adherence has become such an issue. The cause is ineffective communication.

Continue reading “New Study: Non-Adherence Causing Some Diabetes Cases”

Research results were released that make a clearer understanding of the metabolic functions of obesity and its connection to Type 2 diabetes. Research studies are ongoing in regards to using this data about the protein mitoNEET in hopes of creating different medications for the treatment of diabetes.

The protein “mitoNEET” is a major part of the cell’s mitochondrion, which is the cell’s energy powerhouse. MitoNEET binds pioglitzaone (Actos TM) an insulin-sensitizing drug that is used in the treatment of Type 2 diabetes.

Continue reading “New Study on mitoNEET Protein and Type 2 Diabetes”

Study results indicate that women who have survived breast cancer are more apt to develop diabetes after menopause than women who did not suffer from a bout of breast cancer.  These study results were published in the Diabetologia, The Journal of European Association for the Study of Diabetes (EASD).  The study was headed by Dr. Lorraine Lipscombe,   Women’s College Hospital, Women’s College Research Institute, Toronto, Ontario, Canada.

There have been many published reports where results show a connection between diabetes and cancer, cancer of any form.  In particular, though, there is an estimated 20 percent higher risk of diabetes for women after menopause in those who survived breast cancer.

Continue reading “New Study On Post-Menopausal Cancer Survivors & Diabetes”

While diabetes is a common fatal disease in the United States, ovarian cancer is quickly growing to be another one to look out for as well. Now there may be a chance to help cure one with one simple pill.

A study by the Mayo Clinic has shown that the diabetic insulin-sensitizing drug Metformin has shown improvement in patients who are suffering from ovarian cancer. Patients with both diabetes and ovarian cancer and took the drug had a better survival rate than those who did not. The drug also helped to slow the growth of and prevent tumors.

Continue reading “Mayo Study Claims Metformin Helps Ovarian Cancer”

The maker of the injectable insulin Victoza  (aka/ liraglutide), Danish company Novo Nordisk, presented test results at the 9th Annual International Diabetes Federation Western Pacific Region Congress in Kyoto, Japan, on November 27, 2012, that reflected that Victoza is more likely to enable Type 2 diabetics to achieve lower AIC levels during a 26-week period (testing at 12 weeks, 20 weeks and 26 weeks) than does oral Sitagliptin (Januvia) and injectable Exenatide in people with Type 2 diabetes.  The study results indicated that the AIC desired levels were lower than 7.0 during that testing period for the participants in the study.

Continue reading “New Study Results Released on Victoza”

Past studies have shown that if you have diabetes, you are more likely to be diagnosed with Alzheimer’s disease when you get older, and having diabetes even accelerates the Alzheimer’s progression.

Why?  The complete answer is unknown at this time, although many theories have been culled from many different studies.

Continue reading “New Grant Issued To Find Out Why Diabetes Accelerates Alzheimer’s”

According to new research by the Hebrew University of Jerusalem, limiting carbs to dinnertime can help those who are suffering from severe or morbid obesity, reducing the risk for diabetes and cardiovascular risk.

By opting for this diet, a secretion pattern of hormones that are responsible for both satiety and hunger and hormones that are associated with metabolic syndrome are influenced. It can help to prevent diabetes and cardiovascular disease from ever occurring.

Continue reading “Dinnertime Carbs Reduce Diabetes And Cardiovascular Risk”

According to new research obtained by St. Louis’s Washington University School of Medicine, vitamin D can be helpful in unclogging arteries, which causes heart disease, in patients with diabetes.

Researchers report that blood vessels are less likely to clog in patients that have an adequate amount of vitamin D in their body. In patients that have little vitamin D in their body, the immune cells that are near and around the heart become trapped with cholesterol, which will in turn block those blood vessels , causing clogged arteries, heart disease and numerous other heart problems. Vitamin D deficiency is responsible for a lot of health problems.

Continue reading “Vitamin D Helping Diabetics With Clogged Arteries”

According to a new study taken by the University Of Calgary’s Hotchkiss Brian Institute, there is proof that a new drug therapy called nabilione can treat by nerve pain and neuropathy.

Sixty patients with diabetic neuropathy were enrolled in a 12-week placebo controlled clinical study. When the study was over, patients stated that there was less pain and an improvement in both anxiety and sleep as well in taking nabilone as opposed to the placebo.

Dr. Cory Toth, the study’s lead researcher and a neurologist said, “This is a good option to help treat nerve pain due to diabetes, with very few side effects.”

Continue reading “New Study Shows Nabilione Can Treat Diabetic Nerve Pain”

Two genes have been discovered by a group of international researchers that increases the risk of developing diabetes that is associated with kidney disease.

Kidney disease is a common problem when it comes to the complications of diabetes and the disease typically leads to both strokes and heart attacks. Diabetic kidney disease is known world-wide as the leading cause of kidney failure in which a kidney transplant or dialysis is used as treatment.

Researchers led a study from the Queen’s University Belfast, University College Dublin, Harvard University and the University of Helsinki in order to find significant evidence about genes associated with both diabetes and kidney disease.

The study was congratulated by Professor Bernie Hannigan, Director of HSC R&D who said, “This research consortium is tremendously productive. Their dedicated work will immediately benefit patient management and in the longer term can lead to new treatments with both health and economic impacts. Such international research collaboration can result in gains for all partners involved.”

This study is the largest of its kind, 4,750 patients with diabetic kidney disease and nearly 7,000 patients with long-standing diabetes (with no kidney disease) were recruited for the study.

A principal of the study, Professor Peter Maxwell of Queen’s University said, “Currently available drugs cannot cure the kidney failure but may slow its progression. Knowing which patients are most at risk of kidney complications will be helpful in managing their diabetes.”

Over two million DNA markers per person were analyzed and two genes were found (AFF3 and ERBB4) which were increases for kidney disease.

Professor Catherin Godson, lead investigator of the UCD group stated, “These new research findings are very important as they help accelerate development of new and effective therapies.”